# TYRP1

## Overview
The TYRP1 gene encodes tyrosinase-related protein 1, a transmembrane glycoenzyme that plays a pivotal role in the melanin biosynthesis pathway. This protein is primarily involved in the oxidation of intermediates in melanin production and is crucial for the stabilization and function of tyrosinase, another key enzyme in this pathway (Kobayashi2007Direct; Dolinska2019The). TYRP1 is predominantly expressed in melanocytes, where it contributes to pigmentation and protects cells from oxidative stress (Ghanem2011Tyrosinase). Mutations in the TYRP1 gene can lead to pigmentary disorders such as oculocutaneous albinism type 3 (OCA3), underscoring its importance in maintaining normal pigmentation (Kobayashi2007Direct). Additionally, TYRP1 has been implicated in melanoma, where its mRNA levels are associated with poor clinical outcomes, suggesting a potential role in cancer progression (Gilot2017A; Journe2011TYRP1).

## Structure
The TYRP1 gene encodes the tyrosinase-related protein 1, a transmembrane glycoenzyme involved in melanin biosynthesis. The primary structure of TYRP1 includes a sequence of amino acids forming a polypeptide chain, which is crucial for its function in eumelanin synthesis (Patel2021Tyrp1). The secondary structure comprises alpha helices and beta sheets, contributing to the protein's stability and function (Dolinska2020Protein).

The tertiary structure of TYRP1 features several key domains, including an N-terminal signal peptide, an intra-melanosomal domain, a transmembrane α-helix, and a small C-terminal cytoplasmic domain. The intra-melanosomal domain contains a Cys-rich subdomain and a tyrosinase-like subdomain with a binuclear metal-ion binding motif, coordinating zinc ions essential for its catalytic activity (Lai2020Phenylthiourea; Patel2021Tyrp1). The protein also contains five disulfide bridges, three of which are located within an epidermal growth factor (EGF)-like fold, contributing to its structural integrity (Patel2021Tyrp1).

Post-translational modifications of TYRP1 include glycosylation at multiple sites, which are crucial for its stability and function (Dolinska2020Protein). These modifications help maintain the protein's structure and activity within the melanosomes. The protein's quaternary structure is not explicitly detailed in the provided context.

## Function
TYRP1 (tyrosinase-related protein 1) is a crucial component in the melanin biosynthesis pathway, primarily functioning within melanosomes, specialized organelles in melanocytes. It is involved in the oxidation of 5,6-dihydroxyindole-2-carboxylic acid (DHICA) to indole-5,6-quinone-2-carboxylic acid (IQCA), contributing to the quality of melanin produced (Kobayashi2007Direct; Dolinska2019The). TYRP1 also plays a role in stabilizing tyrosinase, another key enzyme in melanin production, by forming heterodimeric complexes with it, which is essential for efficient melanin synthesis (Kobayashi2007Direct; Dolinska2019The). This interaction occurs in various cellular compartments, including the endoplasmic reticulum and melanosomes, indicating its importance in the maturation and function of these organelles (Kobayashi2007Direct).

In addition to its role in pigmentation, TYRP1 is involved in protecting melanocytes from oxidative stress, which is crucial for cellular homeostasis and survival (Ghanem2011Tyrosinase). Mutations in the TYRP1 gene can lead to pigmentary disorders such as oculocutaneous albinism type 3 (OCA3), highlighting its significance in maintaining normal pigmentation and cellular function (Kobayashi2007Direct).

## Clinical Significance
Mutations and alterations in the expression of the TYRP1 gene have significant clinical implications. TYRP1 is associated with oculocutaneous albinism type 3 (OCA3), a condition characterized by reduced pigmentation in the skin, hair, and eyes due to mutations in the gene (Wen2021Long). In melanoma, elevated levels of TYRP1 mRNA are linked to poor clinical outcomes, even when the TYRP1 protein is not detectable. This suggests a non-coding function of TYRP1 mRNA, potentially acting as a miRNA sponge to promote melanoma growth by sequestering tumor-suppressor miRNAs like miR-16 (Gilot2017A). High TYRP1 mRNA expression correlates with shorter distant metastasis-free survival and overall survival in melanoma patients, indicating its prognostic value (Journe2011TYRP1). 

Single nucleotide polymorphisms (SNPs) in the TYRP1 gene, particularly at miR-155 binding sites, can affect TYRP1 expression and refine its prognostic value in melanoma (El2015SNPs). TYRP1 is also a target for CAR-T cell therapy in melanoma, as it is expressed on the surface of tumor cells, making it a viable target for treatment in certain melanoma subtypes (Jilani2024CART).

## Interactions
TYRP1 (tyrosinase-related protein 1) is known to interact with tyrosinase (TYR) in melanocytes, forming heterodimeric complexes that are crucial for the stabilization and function of TYR in melanin synthesis. This interaction has been demonstrated in vivo using chemical crosslinking techniques, which showed that TYRP1 and TYR can be crosslinked and stabilized within melanocytes and melanosomes (Kobayashi2007Direct). TYRP1 is significantly more abundant than TYR in melanocytes, and its presence is essential for the proper trafficking and stabilization of TYR, impacting pigment biosynthesis (Kobayashi2007Direct).

While TYRP1 has been suggested to act as a molecular chaperone for TYR, studies have shown that this protective effect does not involve stable hetero-oligomeric complexes. Instead, TYRP1 may enhance TYR stability through transient interactions or molecular crowding effects (Dolinska2019The). Despite the lack of stable complex formation, TYRP1's role in stabilizing TYR is supported by its ability to protect TYR activity in vitro (Dolinska2019The). These interactions are critical for melanin production and the overall function of melanocytes.


## References


[1. (Ghanem2011Tyrosinase) Ghanem Ghanem and Journé Fabrice. Tyrosinase related protein 1 (tyrp1/gp75) in human cutaneous melanoma. Molecular Oncology, 5(2):150–155, February 2011. URL: http://dx.doi.org/10.1016/j.molonc.2011.01.006, doi:10.1016/j.molonc.2011.01.006. This article has 69 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.molonc.2011.01.006)

[2. (Jilani2024CART) Sameeha Jilani, Justin D. Saco, Edurne Mugarza, Aleida Pujol-Morcillo, Jeffrey Chokry, Clement Ng, Gabriel Abril-Rodriguez, David Berger-Manerio, Ami Pant, Jane Hu, Rubi Gupta, Agustin Vega-Crespo, Ignacio Baselga-Carretero, Jia M. Chen, Daniel Sanghoon Shin, Philip Scumpia, Roxana A. Radu, Yvonne Chen, Antoni Ribas, and Cristina Puig-Saus. Car-t cell therapy targeting surface expression of tyrp1 to treat cutaneous and rare melanoma subtypes. Nature Communications, February 2024. URL: http://dx.doi.org/10.1038/s41467-024-45221-2, doi:10.1038/s41467-024-45221-2. This article has 6 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-45221-2)

[3. (Wen2021Long) Aiping Wen, Le Luo, Chengchao Du, and Xin Luo. Long non‑coding rna mir155hg silencing restrains ovarian cancer progression by targeting the microrna‑155‑5p/tyrosinase‑related protein 1 axis. Experimental and Therapeutic Medicine, August 2021. URL: http://dx.doi.org/10.3892/etm.2021.10672, doi:10.3892/etm.2021.10672. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/etm.2021.10672)

[4. (Journe2011TYRP1) F Journe, H Id Boufker, L Van Kempen, M-D Galibert, M Wiedig, F Salès, A Theunis, D Nonclercq, A Frau, G Laurent, A Awada, and G Ghanem. Tyrp1 mrna expression in melanoma metastases correlates with clinical outcome. British Journal of Cancer, 105(11):1726–1732, November 2011. URL: http://dx.doi.org/10.1038/bjc.2011.451, doi:10.1038/bjc.2011.451. This article has 44 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/bjc.2011.451)

[5. (El2015SNPs) P El Hajj, D Gilot, M Migault, A Theunis, L C van Kempen, F Salés, H Fayyad-Kazan, B Badran, D Larsimont, A Awada, L Bachelot, M-D Galibert, G Ghanem, and F Journe. Snps at mir-155 binding sites of tyrp1 explain discrepancy between mrna and protein and refine tyrp1 prognostic value in melanoma. British Journal of Cancer, 113(1):91–98, June 2015. URL: http://dx.doi.org/10.1038/bjc.2015.194, doi:10.1038/bjc.2015.194. This article has 27 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/bjc.2015.194)

[6. (Lai2020Phenylthiourea) Xuelei Lai, Harry J. Wichers, Montserrat Soler-López, and Bauke W. Dijkstra. Phenylthiourea binding to human tyrosinase-related protein 1. International Journal of Molecular Sciences, 21(3):915, January 2020. URL: http://dx.doi.org/10.3390/ijms21030915, doi:10.3390/ijms21030915. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21030915)

[7. (Dolinska2019The) Monika B. Dolinska, Paul T. Wingfield, Kenneth L. Young, and Yuri V. Sergeev. The tyrp1‐mediated protection of human tyrosinase activity does not involve stable interactions of tyrosinase domains. Pigment Cell &amp; Melanoma Research, 32(6):753–765, June 2019. URL: http://dx.doi.org/10.1111/pcmr.12791, doi:10.1111/pcmr.12791. This article has 20 citations.](https://doi.org/10.1111/pcmr.12791)

[8. (Patel2021Tyrp1) Milan H. Patel, Monika B. Dolinska, and Yuri V. Sergeev. Tyrp1 mutant variants associated with oca3: computational characterization of protein stability and ligand binding. International Journal of Molecular Sciences, 22(19):10203, September 2021. URL: http://dx.doi.org/10.3390/ijms221910203, doi:10.3390/ijms221910203. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms221910203)

[9. (Gilot2017A) David Gilot, Mélodie Migault, Laura Bachelot, Fabrice Journé, Aljosja Rogiers, Emmanuelle Donnou-Fournet, Ariane Mogha, Nicolas Mouchet, Marie-Laure Pinel-Marie, Bernard Mari, Tristan Montier, Sébastien Corre, Arthur Gautron, Florian Rambow, Petra El Hajj, Rania Ben Jouira, Sophie Tartare-Deckert, Jean-Christophe Marine, Brice Felden, Ghanem Ghanem, and Marie-Dominique Galibert. A non-coding function of tyrp1 mrna promotes melanoma growth. Nature Cell Biology, 19(11):1348–1357, October 2017. URL: http://dx.doi.org/10.1038/ncb3623, doi:10.1038/ncb3623. This article has 74 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncb3623)

[10. (Kobayashi2007Direct) Takeshi Kobayashi and Vincent J. Hearing. Direct interaction of tyrosinase with tyrp1 to form heterodimeric complexes in vivo. Journal of Cell Science, 120(24):4261–4268, December 2007. URL: http://dx.doi.org/10.1242/jcs.017913, doi:10.1242/jcs.017913. This article has 65 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.017913)

[11. (Dolinska2020Protein) Monika B. Dolinska, Kenneth L. Young, Claudia Kassouf, Emilios K. Dimitriadis, Paul T. Wingfield, and Yuri V. Sergeev. Protein stability and functional characterization of intra-melanosomal domain of human recombinant tyrosinase-related protein 1. International Journal of Molecular Sciences, 21(1):331, January 2020. URL: http://dx.doi.org/10.3390/ijms21010331, doi:10.3390/ijms21010331. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21010331)